Indeed, Kansal et al. showed that CD19-targeted CD8+CAR-T cells were capable of reversing or deferring lupus manifestations in two murine models (NBZ/W and MRL-lpr), with considerable extension of the animals’ lifespan [60]. Here, CD19 is linked to systemic lupus erythematosus.